Clinical Trial Update: Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of nivolumab and ipilimumab in patients with salivary gland cancer has completed enrollment and posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Salivary Gland Cancer

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Salivary Gland Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-12-18